TY  - GEN
AU  - Rappazzo, C Garrett
AU  - Hsieh, Ching-Lin
AU  - Rush, Scott A
AU  - Esterman, Emma S
AU  - Delgado-Romero, Teresa
AU  - Geoghegan, James C
AU  - Wec, Anna Z
AU  - Sakharkar, Mrunal
AU  - Mas-Lloret, Vicente
AU  - McLellan, Jason S
AU  - Walker, Laura M
PY  - 2022
DO  - 10.1016/j.immuni.2022.07.003
UR  - http://hdl.handle.net/20.500.12105/16032
AB  - Human metapneumovirus (hMPV) is a leading cause of acute lower respiratory tract infections in high-risk populations, yet there are no vaccines or anti-viral therapies approved for the prevention or treatment of hMPV-associated disease. Here, we used...
LA  - eng
PB  - Elsevier
KW  - Antibodies, Neutralizing
KW  - Antibodies, Viral
KW  - Metapneumovirus
KW  - Respiratory Tract Infections
KW  - Aged
KW  - Animals
KW  - Epitopes
KW  - Glycoproteins
KW  - Humans
KW  - Viral Fusion Proteins
KW  - Young Adult
TI  - Potently neutralizing and protective anti-human metapneumovirus antibodies target diverse sites on the fusion glycoprotein
TY  - research article
ER  -